Company intelligence / Profile preview

Retrogen

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Retrogen is a provider of quality genomic and clinical diagnostic services, specializing in high-throughput DNA sequencing, genetic disease analysis, custom panels, and molecular services, supporting researchers and clinicians. Their clinical lab services are CLIA-regulated and College of American Pathologists (CAP) accredited

Therapeutic areas: Women's HealthInfectious DiseasesPulmonologyRare Diseases
Modalities: DNA sequencingGenetic testingGenomic servicesDiagnostic testing
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Retrogen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retrogen.

Explore the full profile